ExodusPoint Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

ExodusPoint Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,548	Closed	-$120K	–	2322
2022 Q3	$120K	Buy	+14,548	New	+$112K	﹤0.01%	1723
2022 Q2	–	Sell	-11,044	Closed	-$62K	–	2770
2022 Q1	$62K	Sell	11,044 -220	-2%	-$906	﹤0.01%	2049
2021 Q4	$53K	Buy	+11,264	New	+$69.9K	﹤0.01%	2025
2021 Q3	–	Sell	-75,015	Closed	-$494K	–	2927
2021 Q2	$494K	Buy	75,015 +54,943	+274%	+$379K	0.01%	1450
2021 Q1	$147K	Buy	+20,072	New	+$173K	﹤0.01%	1926
2020 Q3	–	Sell	-37,924	Closed	-$195K	–	2449
2020 Q2	$195K	Buy	+37,924	New	+$239K	0.01%	1523
2020 Q1	–	Sell	-1,770	Closed	-$11K	–	1892
2019 Q4	$11K	Buy	+1,770	New	+$13K	﹤0.01%	1473

Other funds holding AVEO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NAM

Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

ACM

AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return

ExodusPoint Capital Management's AVEO Position: Q4 2022 in Review

ExodusPoint Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2022, closing a stake of 14,548 shares — an estimated $120K sold.

ExodusPoint Capital Management first reported a position in AVEO in Q4 2019 and held it in 7 quarters. The position peaked at $494K in Q2 2021. 110 funds tracked by Wall St. Rank hold AVEO as of Q4 2022.

ExodusPoint Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2022 after selling out during the quarter.
ExodusPoint Capital Management sold 14,548 AVEO Pharmaceuticals, Inc. shares in Q4 2022, an estimated $120K.
ExodusPoint Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2019 and held it in 7 quarters.
ExodusPoint Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $494K in Q2 2021.
110 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2022.

Based on ExodusPoint Capital Management's 13F filing for Q4 2022, filed 13 Feb 2023.